The Association of British HealthTech Industries (ABHI) recently launched the UK Healthcare Pavilion, a single platform to unite MedTech companies with the UK healthcare sectors, both NHS and private. Forte Medical is very happy to have joined such an august and respected portfolio of companies, providers and innovators. Our entry features films about our technology featuring advocates, policy makers, healthcare professionals and the AHSN Network. Click here to view.
https://forte-medical.co.uk/wp-content/uploads/2021/02/LiamMike.png 321 636 Giovanna https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png Giovanna2021-02-25 14:16:152021-02-25 14:16:15Forte Medical joins ABHI UK Healthcare Pavilion
https://forte-medical.co.uk/wp-content/uploads/2020/04/29.jpg 371 513 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2019-01-17 16:23:302020-09-14 10:32:42Urine Is Liquid Gold When It Comes To Testing
Today’s Hippocratic Post features an overview on the importance of urine and the evidence supporting why our technology plays such a vital role in enabling right-first-time diagnosis and treatment.
https://forte-medical.co.uk/wp-content/uploads/2020/04/31-scaled.jpg 1652 2560 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2019-01-16 10:24:412020-09-14 10:33:08ABHI Reception – The Role of HealthTech In Saving Lives
We attended the ABHI Parliamentary Reception last night and CEO Giovanna Forte had the opportunity to speak with The Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care about how Forte Medical’s technology could save the NHS £1.2bn in unnecessary retesting of urine samples, cancellation of operations, over prescribing of unnecessary antibiotics and much more.
The event, attended by over 200 delegates celebrated the critical role HealthTech plays in improving lives and supporting the NHS.
For more information, the ABHI document can be accessed here
https://forte-medical.co.uk/wp-content/uploads/2020/04/33.jpeg 400 800 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2019-01-10 15:41:402020-09-14 10:33:29IPC 2019 – We’re Exhibiting!
The future of preventative care, infection control, antimicrobial resistance and patient safety are routinely undermined by lazy attitudes towards urine collection, the most common diagnostic process. Despite mounting evidence to support the need for a respected protocol, incumbent methods are failing modern medicine, patient health and the work of diligent clinicians.
Want to know more about our mission – visit us on stand 23 – and see first hand our world-class diagnostic specimen collection technology; Peezy Midstream reduces false-positive dipped urines by almost 70% and specimen contamination to just 2%. Current contamination is 23.5%, leading to 1 in 4 failed urine specimens – that’s over 14m annually or 56,000 every day. The unique Peezy Midstream delivers diagnostic integrity leading to targeted treatment; it helps address growing problems of infection control, unnecessary broad-spectrum antibiotic prescribing, AMR, and failed treatment of conditions that can become chronic.
https://forte-medical.co.uk/wp-content/uploads/2020/04/43.jpg 1074 1538 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2018-10-12 14:51:432020-09-14 10:37:31Peezy Midstream Case Study at NHS NIHR Conference 2018
Back in March of this year, the NHS National Institute for Health Research contacted Forte Medical, asking for a case study demonstrating how their research has assisted the launch of Peezy Midstream.
A few months earlier the NIHR in conjunction with the West Midlands AHSN conducted a valuable Usability Study on our diagnostic device. Results were excellent and have assisted us with adoption training and reassurance to HCPs and patients alike that using Peezy Midstream is far, far easier than trying to deliver this elusive urine specimen any other way …
The case study presented by Giovanna Forte on 10th October 2018 was very well received and has already led to enquiries from Primary Care clinicians who can see the benefit of right-first-time diagnoses for UTI and other common conditions that can take up so much GP time when left untreated.
https://forte-medical.co.uk/wp-content/uploads/2020/04/55.jpeg 411 734 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2018-06-11 15:43:552020-09-14 10:39:56Disruptive TV: Giant Live Health Innovators
Barry Shrier, Founder of annual health innovation event Giant Live, presents the third Disruptor Giant Health Innovators TV interview featuring Giovanna Forte, CEO of Forte Medical, Francis White from AliveCor, Dr Sophie Bostock of Sleepio and Etienne Bourdon from Healthy Health. Watch the half-hour programme here with Disruptive Live
https://forte-medical.co.uk/wp-content/uploads/2020/04/59.jpg 300 300 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2018-04-10 09:00:012020-09-14 10:40:52UTIs in the elderly – and why it matters
Giovanna Forte was invited by Age Space to explain further.
Read the article in full here
https://forte-medical.co.uk/wp-content/uploads/2020/04/62.jpg 380 634 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2018-02-12 17:29:092020-09-14 10:41:34Peezy Animation: instructions for use
How easy is Peezy? Very! Click here to see our new animation showing five simple steps that deliver right-first-time urine specimen collection. Any clinician will know that contamination can prevent or delay diagnoses; Peezy makes prompt analysis, diagnosis and treatment simple and cost effective.
https://forte-medical.co.uk/wp-content/uploads/2020/04/67.jpg 589 540 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2018-01-23 13:38:482020-09-14 10:43:04£434 million spent on treating unplanned UTI admissions
It costs so little to put it right: “The NHS spent £434 million in 2013/14 on treating184,000 patients in unplanned admissions associated with a UTI. UTIs are the second-largest single group of healthcare-associated infections in the UK, accounting for 19.7% of all hospital acquired infections.”
https://forte-medical.co.uk/wp-content/uploads/2020/04/69.jpg 273 525 admin https://forte-medical.co.uk/wp-content/uploads/2021/07/forte_logo_web-300x300.png admin2017-12-11 18:00:502020-09-14 10:44:07Preventing Infections and Reducing AMR
We have been talking prevention for some time so are pleased to see this report from Public Health England advocating right-first-time devices.